東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Cancer- Diagnosis." ]

切換: 標籤 | MARC模式 | ISBD

Tumor liquid biopsies

Schaffner, Florence.

FindBook

Google Book

Amazon

博客來

Tumor liquid biopsies

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Tumor liquid biopsies/ edited by Florence Schaffner, Jean-Louis Merlin, Nikolas von Bubnoff.
其他作者:	Schaffner, Florence.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	vi, 368 p. :ill., digital ;24 cm.
內容註:	Circulating Tumor Cells: Pathophysiology of Tumor Cell Release into the Circulation and characterization of CTC -- CTC enrichment technologies -- Genotyping of CTC :example Lung cancer -- CTC in Breast Cancer: a clinical approach -- Circulating Tumor DNA: Pathophysiology of ctDNA Release into the Circulation and its characterization -- Enrichment and Analysis of ctDNA -- ctDNA in Lung Cancer -- ctDNA in Breast Cancer -- ctDNA in Colorectal Cancer -- Dynamic Treatment Stratification using ctDNA -- Circulating Tumor RNA: Noncoding Tumor RNAs: Pathophysiology of Release and Techniques of Detection -- Circulating miRNAs as Biomarker in Cancer -- Plasma Subcompartments as Source for Tumor derived Biomarkers: Exosomes and Vesicles as Biomarker in Cancer -- Quantitative proteomic Analysis of Plasma in Cancer.
Contained By:	Springer eBooks
標題:	Tumors - Diagnosis. -
電子資源:	https://doi.org/10.1007/978-3-030-26439-0
ISBN:	9783030264390

Tumor liquid biopsies
Tumor liquid biopsies[electronic resource] /edited by Florence Schaffner, Jean-Louis Merlin, Nikolas von Bubnoff. - Cham :Springer International Publishing :2020. - vi, 368 p. :ill., digital ;24 cm. - Recent results in cancer research,v.2150080-0015 ;. - Recent results in cancer research ;v.215..

Circulating Tumor Cells: Pathophysiology of Tumor Cell Release into the Circulation and characterization of CTC -- CTC enrichment technologies -- Genotyping of CTC :example Lung cancer -- CTC in Breast Cancer: a clinical approach -- Circulating Tumor DNA: Pathophysiology of ctDNA Release into the Circulation and its characterization -- Enrichment and Analysis of ctDNA -- ctDNA in Lung Cancer -- ctDNA in Breast Cancer -- ctDNA in Colorectal Cancer -- Dynamic Treatment Stratification using ctDNA -- Circulating Tumor RNA: Noncoding Tumor RNAs: Pathophysiology of Release and Techniques of Detection -- Circulating miRNAs as Biomarker in Cancer -- Plasma Subcompartments as Source for Tumor derived Biomarkers: Exosomes and Vesicles as Biomarker in Cancer -- Quantitative proteomic Analysis of Plasma in Cancer.

This book is a comprehensive guide to the techniques, clinical applications, and benefits of the different forms of liquid biopsy employed in patients with a variety of tumor types, including lung, breast and colorectal cancer. Offering detailed explanations, it discusses the how changes in tumors can be tracked using these cutting-edge technologies, which enable the detection and analysis of diverse circulating biomarkers: tumor cells, tumor DNA, tumor RNA (free or in exosomes), and fluid biomarkers identifiable by means of targeted proteomics. The use of such advanced technologies is enabling us to tackle questions and problems in a way that was not possible just a few years ago. We now have at our disposal an effective means of overcoming the problem of intratumor heterogeneity, which has limited the value of conventional biopsy approaches. As a consequence, oncology practice is about to change radically, toward truly personalized precision medicine. This book provides both clinicians and researchers with a thorough and up-to-date overview of progress in the field.

ISBN: 9783030264390

Standard No.: 10.1007/978-3-030-26439-0doiSubjects--Topical Terms:

823048
Tumors
--Diagnosis.

LC Class. No.: RC255

Dewey Class. No.: 616.994075

Tumor liquid biopsies
LDR:02929nmm a2200337 a 4500 001 2214343
003 DE-He213
005 20200304103913.0
006 m d
007 cr nn 008maaau
008 201118s2020 gw s 0 eng d
020 $a 9783030264390 $q (electronic bk.)
020 $a 9783030264383 $q (paper)
024 7 $a 10.1007/978-3-030-26439-0 $2 doi
035 $a 978-3-030-26439-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC255
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994075 $2 23
090 $a RC255 $b .T925 2020
245 0 0 $a Tumor liquid biopsies $h [electronic resource] / $c edited by Florence Schaffner, Jean-Louis Merlin, Nikolas von Bubnoff.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a vi, 368 p. : $b ill., digital ; $c 24 cm.
490 1 $a Recent results in cancer research, $x 0080-0015 ; $v v.215
505 0 $a Circulating Tumor Cells: Pathophysiology of Tumor Cell Release into the Circulation and characterization of CTC -- CTC enrichment technologies -- Genotyping of CTC :example Lung cancer -- CTC in Breast Cancer: a clinical approach -- Circulating Tumor DNA: Pathophysiology of ctDNA Release into the Circulation and its characterization -- Enrichment and Analysis of ctDNA -- ctDNA in Lung Cancer -- ctDNA in Breast Cancer -- ctDNA in Colorectal Cancer -- Dynamic Treatment Stratification using ctDNA -- Circulating Tumor RNA: Noncoding Tumor RNAs: Pathophysiology of Release and Techniques of Detection -- Circulating miRNAs as Biomarker in Cancer -- Plasma Subcompartments as Source for Tumor derived Biomarkers: Exosomes and Vesicles as Biomarker in Cancer -- Quantitative proteomic Analysis of Plasma in Cancer.
520 $a This book is a comprehensive guide to the techniques, clinical applications, and benefits of the different forms of liquid biopsy employed in patients with a variety of tumor types, including lung, breast and colorectal cancer. Offering detailed explanations, it discusses the how changes in tumors can be tracked using these cutting-edge technologies, which enable the detection and analysis of diverse circulating biomarkers: tumor cells, tumor DNA, tumor RNA (free or in exosomes), and fluid biomarkers identifiable by means of targeted proteomics. The use of such advanced technologies is enabling us to tackle questions and problems in a way that was not possible just a few years ago. We now have at our disposal an effective means of overcoming the problem of intratumor heterogeneity, which has limited the value of conventional biopsy approaches. As a consequence, oncology practice is about to change radically, toward truly personalized precision medicine. This book provides both clinicians and researchers with a thorough and up-to-date overview of progress in the field.
650 0 $a Tumors $x Diagnosis. $3 823048
650 0 $a Cancer $x Diagnosis. $3 999137
650 0 $a Biopsy. $3 1360224
650 1 4 $a Oncology. $3 751006
650 2 4 $a Pathology. $3 643180
650 2 4 $a Cancer Research. $3 891172
700 1 $a Schaffner, Florence. $3 3444696
700 1 $a Merlin, Jean-Louis. $3 3444697
700 1 $a von Bubnoff, Nikolas. $3 3444698
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Recent results in cancer research ; $v v.215. $3 3444699
856 4 0 $u https://doi.org/10.1007/978-3-030-26439-0
950 $a Medicine (Springer-11650)